The global localized temperature therapy products market is set to record a market value of US$ 1,752.9 million in 2023 pushing the market size to US$ 3,055.6 million in 2033. A CAGR of 5.7% indicates positive market growth over the forecast period.
An increase in road accidents and sports-related injuries, the rising elderly population, and the incidence of diabetic foot ulcers, along with the need for advanced treatment are factors driving the demand for the localized temperature therapy products market.
The market is anticipated to show favorable growth in the forthcoming years with growing demand for pharmaceutical companies, for pain management therapy focusing on geriatrics. The localized temperature therapy products market holds nearly 31% market value share of US$ 5.2 billion pain management devices market in 2023. In addition, increased awareness about reconstructive procedures is driving the demand for the market for localized temperature therapy products. Improved emergency room procedures and increased cost-effectiveness add to the growing demand for better quality.
In particular, developing economies throughout Asia and Latin America are experiencing lucrative growth opportunities as healthcare applications increase and global manufacturing grows. A surge in therapeutic applications for geriatric users is also expected to support long-term growth prospects.
The market has experienced a substantial expansion in recent years, as better access to healthcare services has allowed injury and pain relief therapies to become more widespread. In the past few years, non-surgical, pharmaceutical-free treatments have gained in popularity, mainly due to their reduced risk of side effects and ease of use.
Localized temperature therapy improves blood flow and oxygenation. Innovations such as microwaves and electric products provide more efficacy, which leads to a wide range of applications. As a result of road accidents, sports injuries, and fractures of bones and tendons, market demand for these products has increased. In contrast, alternatives like reusable bags and herbal medications may be less effective at preventing growth.
Attributes | Details |
---|---|
Localized Temperature Therapy Products Market Value (2023) | US$ 1,752.9 million |
Localized Temperature Therapy Products Market Expected Value (2033) | US$ 3,055.6 million |
Localized Temperature Therapy Products Market Projected CAGR (2023 to 2033) | 5.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales in the global localized temperature therapy products market are forecast to increase at a 5.7% CAGR, in comparison to the 5.3% CAGR registered between 2017 to 2022.
The high demand for localized temperature therapy products can be broadly contributed to the growth in road accidents and sports injuries. Road accidents comprise a significant portion of the international burden of orthopedic injuries.
As per the ASIRT (Association of System Integrators and Retailers in Technology), it is estimated that nearly 51 million people get injured in road accidents every year in the United States. As per the data from the WHO, traffic injuries and road accidents are projected to be the ninth primary cause of death worldwide, which is predicted to become the seventh leading cause of trauma-related deaths by 2030.
Historical CAGR | 5.3% |
---|---|
Historical Market Value (2022) | US$ 1,647.7 million |
Forecast CAGR | 5.7% |
Localized temperature therapy products relieve pain and inflammation in specific areas of the body. The market for these products is driven by several factors, including:
Chronic pain affects millions of people worldwide and is a leading contributor to disability and decreased quality of life. As a result, non-pharmacological pain management options are growing, such as localized temperature therapy products.
For instance, localized temperature therapy products such as cryotherapy and thermotherapy have been shown to reduce inflammation and pain, both in the short and long term. Localized temperature therapy products speed recovery from sports injuries and reduce pain and inflammation. Moreover, athletic injuries and weekend warrior injuries are common injuries that need such therapies.
With advances in medical research, there is a growing understanding of the benefits of localized temperature therapy in managing pain and promoting healing. This drives demand for effective and easy-to-use products.
For instance, medical-grade reusable hot and cold therapy packs are gaining popularity due to their efficacy in reducing inflammation and providing pain relief.
The localized temperature therapy products market is also likely to expand due to wearable devices and smart temperature therapy products. For instance, the Hestia Sensor by Hestia Heat Technologies is a wearable device that monitors body temperature and provides real-time feedback to the user to optimize temperature therapy. These products are designed to be convenient, easy to use and provide customized therapy based on the individual's needs.
Concerns about the side effects and potential addiction associated with traditional pain medications have led to an increased focus on non-invasive and non-pharmacological therapies. For instance, many healthcare providers recommend non-invasive treatments such as acupuncture, chiropractic care, and massage to manage chronic pain. Many people find localized temperature therapy products effective and safe.
People are increasingly interested in taking care of their health and well-being, which drives the demand for home-based treatments. Pain relief without medical intervention is possible with localized temperature therapy products. They are easy to use at home and provide effective pain relief.
The availability of alternative therapies for orthopedic disorders, such as rubber rolls or traditional elastic bands on blood flow restrictors used in joint replacement, is expected to restrain the global localized temperature therapy product market growth.
Various manufacturers of localized temperature therapy products are concentrating on the development of new products. But, frequent device failures are among the primary factors that are impacting sales, which is hindering the market growth to some extent. Therefore, alternative treatment options are being adopted.
In addition, rising competition from natural pain relief products and the increasing popularity of reusable products are decreasing the sales prospects of localized temperature therapy products.
Based on the product category, localized heat therapy product is anticipated to hold the maximum share of 56.9% in 2023, expanding at a rate of nearly 6.2% during the forecast period. Out of all the products in the market, localized heat therapy products hold a relatively higher share and are witnessing fast-growing demand.
The segment share, with the hot water bottles in the market, holds for about 48% of the total market share due to its effectiveness in long-term pain management processes, together with higher adoption rates from worldwide adult demographics. Moreover, long-term exposure to heat treatment can be utilized for serious pain cases when compared with cold therapy options, adding to the adoption for the long term.
By area of application, the back segment leads the market as it is estimated to account for 25.8% of the total market revenue share in 2023.
Localized temperature therapy products are observing demand for healthcare applications for the shoulder, neck, back, knee, and others. Heat therapy has found wide use in dealing with lumbar spinal injuries as well as minor back pain, by increasing blood flow, and the subsequent growth in oxygen and nutrient concentrations to injured tissue. In addition, heat therapy has a high potential in improving back flexibility, which is significant in maintaining back health.
By distribution channel, retail pharmacies are anticipated to hold the maximum share of 48.8% in 2023, expanding at a rapid rate of 5.5% CAGR during the forecast period.
The several forms of localized temperature therapy products are widely available online, in retail, and in hospital pharmacies. Out of this distribution channel, retail pharmacies hold around half of the total revenue share.
The surge of sales from retail pharmacies can be owing to the extensive penetration of the distribution channel, easy access to patients, and low costs of products, looking for pain treatment options for home use that is expected to help the growth aspects over the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Countries Leading in Localized Temperature Therapy Products Market: Country-wise Analysis
Region | North America |
---|---|
Country | United States |
Historic CAGR | 4.8% |
Forecasted CAGR | 5.5% |
Absolute Dollar Growth | US$ 40 million |
Market Value (2033) | US$ 1,092 million |
Region | North America |
---|---|
Country | Canada |
Historic CAGR | 4.6% |
Forecasted CAGR | 3.0% |
Absolute Dollar Growth | US$ 1.7 million |
Market Value (2033) | US$ 53.3 million |
Region | Europe |
---|---|
Country | Germany |
Historic CAGR | 6.4% |
Forecasted CAGR | 7.2% |
Absolute Dollar Growth | US$ 8 million |
Market Value (2033) | US$ 197.1 million |
Region | Europe |
---|---|
Country | United Kingdom |
Historic CAGR | 5.2% |
Forecasted CAGR | 6.2% |
Absolute Dollar Growth | US$ 5.3 million |
Market Value (2033) | US$ 157.8 million |
Region | Asia Pacific |
---|---|
Country | China |
Historic CAGR | 7.6% |
Forecasted CAGR | 7.2% |
Absolute Dollar Growth | US$ 16.8 million |
Market Value (2033) | US$ 383.2 million |
The United States is estimated to account for around 94.1% of the North American localized temperature therapy products market in 2023.
The dominant share of the United States can mainly be owing to the increasing emphasis by key market players on the management of sports injuries, interest in heat treatment for lower limb injuries, and increasing occurrences of musculoskeletal disorders in the United States.
As per the American Cancer Society, induced hyperthermia has demonstrated potential in cancer therapy. Subsequently, the interest in localized heat therapy products is expected to gain traction over the forecast period.
In addition, healthcare professionals in the country are using these localized temperature therapy products in the management of exhaustion and to avoid heat stroke, which is likely to support the growth of the market in the United States.
Germany is estimated to account for 21.5% of Europe’s localized temperature therapy products market in Europe in 2023.
Germany is expected to lead the market owing to the development of new thermotherapy products to cater to the requirements of heat-sensitive ailments and the growing access of patients to better healthcare facilities when compared with other countries in the world.
As per the European Environment Agency, the country has been exposed to a higher frequency of extreme cold and heat waves in the past years. Subsequently, the rates of mortality and morbidity have also risen, especially among the susceptible population.
Moreover, this trend is likely to worsen in the coming years, making the requirement for localized temperature therapy products progressively important in the country over the forecast period.
The localized temperature therapy products market in China is estimated to be worth US$ 178.2 million in 2023 in the global market.
China is expected to display a relatively rapid growth rate during the forecast period. For example, researchers in China have found favorable outcomes in the utilization of targeted temperature for the management of patients recovering from a heart attack.
Localized temperature therapy products are observing increased adoption for induced hypothermia for longer durations, in circumstances of return of spontaneous circulation, to enhance neurological outcomes that generate a suitable environment for adoption and sale of offerings from the market. Water blanket products and gel pad cooling devices are specifically gaining traction for these applications in the country.
Demand for localized temperature therapy products in Japan is expected to rise at around 6.1% CAGR over the forecast period.
The growing geriatric population in Japan is one of the primary factors driving the growth of the market in Japan. As an individual grows old, the occurrence of chronic pain surges, and it remains growing over 65 years of age. The geriatric population widely suffers from arthritis, joint and bone disorders, cancer, and other chronic diseases associated with pain.
Japan’s geriatric population is growing rapidly. According to the World Economic Forum in 2019, around 25% of the total population is over 65 years old in Japan and this is likely to increase to 60% by 2060. Due to the growth in the geriatric population, demand for localized temperature therapy products in the country is expected to grow over the forecast period.
Recent Development
Companies operating in the localized temperature therapy products market are moderately competitive by nature, with the presence of several key players. These players are involved in several strategic alliances.
The agreement and system automation accelerates the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market. A few of the recent instances include:
Manufacturers of localized temperature therapy products can adopt several strategies to get better growth opportunities in the market. Here are some of them:
Attributes | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | US$ billion for Value and MT for Volume |
Key Regions Covered | North America; Latin America; Europe; The Middle East and Africa; East Asia |
Key Countries Covered | United States, Canada, Brazil, Mexico, Chile, Peru, Germany, United Kingdom, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Türkiye |
Key Segments Covered | Product, Area of Application, Distribution Channel, Region |
Key Companies Profiled | Medtronic plc; Cardinal Health; Medline Industries Inc.; Cincinnati Sub Zero; B.u.W. Schmidt; Pic Solution; Rapid Aid; 3M; McKesson Corporation; Mölnlycke Health Care AB; Breg Inc.; Kobayashi Pharmaceutical (H.K.) Co. Inc. |
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The market is valued at US$ 1,752.9 million in 2023.
B.u.W. Schmidt, Pic Solution, Rapid Aid are the top market players.
The market is forecast to experience a CAGR of 5.7% through 2033.
The market is predicted to reach US$ 3,055.6 million by 2033.
The market registered a CAGR of 5.3% from 2018 to 2022.
1. Executive Summary | Localized Temperature Therapy Products Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Localized Neonatal Therapy Product
5.3.1.1. Warming Mattress
5.3.1.2. Infant Heel warmers
5.3.2. Localized Heat Therapy Product
5.3.2.1. Hot water bottles
5.3.2.2. Heat lamps
5.3.2.3. Paraffin bath
5.3.2.4. Gel hot packs
5.3.2.5. Others
5.3.3. Localized Cold Therapy Product
5.3.3.1. Vapocoolant sprays
5.3.3.2. Thermal cooling blanket
5.3.3.3. Disposable ice bags
5.3.3.4. Cold packs
5.3.3.5. Others
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Neck
6.3.2. Shoulder
6.3.3. Knee
6.3.4. Back
6.3.5. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel , 2023 to 2033
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.4. Y-o-Y Growth Trend Analysis By Distribution Channel , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Distribution Channel , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By Distribution Channel
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By Distribution Channel
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By Distribution Channel
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Product
12.2.3. By Application
12.2.4. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By Distribution Channel
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By Application
13.2.4. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By Distribution Channel
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product
14.2.3. By Application
14.2.4. By Distribution Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By Distribution Channel
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Application
15.2.4. By Distribution Channel
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Application
15.3.4. By Distribution Channel
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Application
16.1.2.3. By Distribution Channel
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Application
16.2.2.3. By Distribution Channel
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Application
16.3.2.3. By Distribution Channel
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Application
16.4.2.3. By Distribution Channel
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Application
16.5.2.3. By Distribution Channel
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Application
16.6.2.3. By Distribution Channel
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Application
16.7.2.3. By Distribution Channel
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Application
16.8.2.3. By Distribution Channel
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Application
16.9.2.3. By Distribution Channel
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Application
16.10.2.3. By Distribution Channel
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Application
16.11.2.3. By Distribution Channel
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Application
16.12.2.3. By Distribution Channel
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Application
16.13.2.3. By Distribution Channel
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Application
16.14.2.3. By Distribution Channel
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Application
16.15.2.3. By Distribution Channel
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Application
16.16.2.3. By Distribution Channel
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Application
16.17.2.3. By Distribution Channel
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Application
16.18.2.3. By Distribution Channel
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Application
16.19.2.3. By Distribution Channel
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Application
16.20.2.3. By Distribution Channel
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Application
16.21.2.3. By Distribution Channel
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Application
17.3.4. By Distribution Channel
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Medtronic plc
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Cardinal Health
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Medline Industries Inc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Cincinnati Sub Zero
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. B.u.W. Schmidt
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Pic Solution
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Rapid Aid
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. 3M
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. McKesson Corporation
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Mölnlycke Health Care AB
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Breg Inc.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Kobayashi Pharmaceutical Co. Inc.
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports